Zobrazeno 1 - 10
of 16
pro vyhledávání: '"M. A. Ussery"'
Autor:
E. Dawn Flick, Jeff P. Sharman, Neil E. Kay, David L. Grinblatt, Charles M. Farber, Kristen A. Sullivan, Anthony R. Mato, Sarah M. Gressett Ussery, Mecide Gharibo, Christopher R. Flowers, Arlene S. Swern, Chadi Nabhan, Nicole Lamanna, Matthew S. Davids, Pavel Kiselev
Publikováno v:
Blood Advances. 4:1407-1418
Optimal treatment of chronic lymphocytic leukemia (CLL) remains unclear. The Connect CLL Registry, a United States–based multicenter prospective observational cohort study, enrolled 1494 patients between 2010 and 2014 from predominantly community-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0a6f2b9c3da27eea1150f1d3a246b06
https://doi.org/10.1182/bloodadvances.2019001145
https://doi.org/10.1182/bloodadvances.2019001145
Autor:
E. Marley, J. Liticker, S. M. Gressett Ussery, Sachin R Shah, Udit Verma, Yull Edwin Arriaga, Jonathan E. Dowell
Publikováno v:
Annals of Oncology. 24:960-965
BACKGROUND A previous study has shown that shorter bevacizumab infusions (0.5 mg/kg/min) can be safely administered without increasing the risk of infusion-related hypersensitivity reactions (HSRs). However, the risk of proteinuria and hypertension i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afc1e66f7ea9300023cadb836ad0e6fd
https://doi.org/10.1093/annonc/mds593
https://doi.org/10.1093/annonc/mds593
Publikováno v:
Journal of Oncology Practice. 7:13-17
Purpose: Clinicians typically cap an obese patient’s chemotherapy regimen as a result of concern for excessive toxicity, without adequate clinical evidence. The purpose of this study was to evaluate the incidence of grade 3 or 4 myelosuppression in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327bc584f306ad8b2175fb8f84d1984e
https://doi.org/10.1200/jop.2010.000045
https://doi.org/10.1200/jop.2010.000045
Publikováno v:
Journal of pediatric hematology/oncology. 37(2)
Therapy with the tyrosine kinase inhibitor imatinib mesylate has become standard initial treatment for adult and pediatric patients with chronic myelogenous leukemia. Long-term follow-up data are now available in the adult population, and the toxicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a71444a6f9fbe092399adec593f98408
https://pubmed.ncbi.nlm.nih.gov/25374285
https://pubmed.ncbi.nlm.nih.gov/25374285
Autor:
M A Ussery, S J Allen, Raymond F. Schinazi, Julie M. Cherrington, J P Sommadossi, Andrew Mulato, Michael D. Fuller, S C Kunder, Ming S. Chen, Z Lesnikowski
Publikováno v:
Antimicrobial Agents and Chemotherapy. 40:1270-1273
The inhibitory effects of several nucleoside triphosphate analogs on Rauscher murine leukemia virus (RMuLV) and human immunodeficiency virus (HIV) type 1 reverse transcriptases (RTs) were studied. With RNA as the template, the apparent K(m) and appar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15cfa7966c6b3a4e956d4793902c9d3e
https://doi.org/10.1128/aac.40.5.1270
https://doi.org/10.1128/aac.40.5.1270
Publikováno v:
Antimicrobial Agents and Chemotherapy. 37:71-77
Rationally designed synthetic inhibitors of retroviral proteases inhibit the processing of viral polyproteins in cultures of human immunodeficiency virus type 1 (HIV-1)-infected T lymphocytes and, as a result, inhibit the infectivity of HIV-1 for suc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9657b416d3470ad227d3fd93b6716d19
https://doi.org/10.1128/aac.37.1.71
https://doi.org/10.1128/aac.37.1.71
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 20(1)
The purpose of this study was to evaluate the incidence of acute renal failure (ARF) in patients with mild to moderate renal dysfunction, receiving renally adjusted zoledronic acid (ZA) and compare it to patients with normal baseline renal function,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73e1a4210c11cf28ed03244cb788be77
https://pubmed.ncbi.nlm.nih.gov/21197550
https://pubmed.ncbi.nlm.nih.gov/21197550
Autor:
M. A. Ussery, L. Barthel‐Rosa, W. M. Shannon, J. J. Kirsi, G. D. Kini, M. J. Phelan, E. M. Schubert, R. K. Robins, B. Gabrielsen
Publikováno v:
ChemInform. 26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce80b53627b89a9ff506b8aad20597e9
https://doi.org/10.1002/chin.199547274
https://doi.org/10.1002/chin.199547274
Publikováno v:
ChemInform. 27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40ecbc94bd611a7f9b3821c5904f8c5a
https://doi.org/10.1002/chin.199642235
https://doi.org/10.1002/chin.199642235
Autor:
John W. Huggins, M. A. Ussery, L. Barthel‐Rosa, Debbie Kefauver, B. Gabrielsen, T. P. Monath, G N Chmurny, C See, E. M. Schubert, M. J. Phelan
Publikováno v:
Journal of Medicinal Chemistry. 35:3231-3238
Ten, hitherto unreported, analogues of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride (2a, ribamidine) and methyl carboximidate 5 have been synthesized. These include the N-cyano (2b), N-alkyl (2c-e), N-amino acid (2f-h), N,N'-di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f9f4148ddba5653d91b3b0d76839d1b
https://doi.org/10.1021/jm00095a020
https://doi.org/10.1021/jm00095a020